K.H. Bohuslavizki
Department of Nuclear Medicine
University Hospital Eppendorf
Hamburg
Germany
Name/email consistency: high
- Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer. Bohuslavizki, K.H., Klutmann, S., Bleckmann, C., Brenner, W., Lassmann, S., Mester, J., Henze, E., Clausen, M. Strahlenther. Onkol (1999)
- Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study. Bohuslavizki, K.H., Klutmann, S., Brenner, W., Mester, J., Henze, E., Clausen, M. J. Clin. Oncol. (1998)